IRIS Accounts Production v22.2.0.402 07487836 Board of Directors Board of Directors 1.1.21 31.12.21 31.12.21 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure074878362020-12-31074878362021-12-31074878362021-01-012021-12-31074878362019-12-31074878362020-01-012020-12-31074878362020-12-3107487836ns16:EnglandWales2021-01-012021-12-3107487836ns15:PoundSterling2021-01-012021-12-3107487836ns11:Director12021-01-012021-12-3107487836ns11:Director22021-01-012021-12-3107487836ns11:PrivateLimitedCompanyLtd2021-01-012021-12-3107487836ns11:SmallEntities2021-01-012021-12-3107487836ns11:AuditExempt-NoAccountantsReport2021-01-012021-12-3107487836ns11:SmallCompaniesRegimeForDirectorsReport2021-01-012021-12-3107487836ns11:SmallCompaniesRegimeForAccounts2021-01-012021-12-3107487836ns11:FullAccounts2021-01-012021-12-3107487836ns11:CompanySecretary12021-01-012021-12-3107487836ns11:RegisteredOffice2021-01-012021-12-3107487836ns6:CurrentFinancialInstruments2021-12-3107487836ns6:CurrentFinancialInstruments2020-12-3107487836ns6:Non-currentFinancialInstruments2021-12-3107487836ns6:Non-currentFinancialInstruments2020-12-3107487836ns6:ShareCapital2021-12-3107487836ns6:ShareCapital2020-12-3107487836ns6:SharePremium2021-12-3107487836ns6:SharePremium2020-12-3107487836ns6:RetainedEarningsAccumulatedLosses2021-12-3107487836ns6:RetainedEarningsAccumulatedLosses2020-12-3107487836ns6:PlantMachinery2021-01-012021-12-3107487836ns6:FurnitureFittings2021-01-012021-12-3107487836ns6:ComputerEquipment2021-01-012021-12-3107487836ns6:PlantMachinery2020-12-3107487836ns6:FurnitureFittings2020-12-3107487836ns6:ComputerEquipment2020-12-3107487836ns6:PlantMachinery2021-12-3107487836ns6:FurnitureFittings2021-12-3107487836ns6:ComputerEquipment2021-12-3107487836ns6:PlantMachinery2020-12-3107487836ns6:FurnitureFittings2020-12-3107487836ns6:ComputerEquipment2020-12-3107487836ns6:ComputerEquipmentns6:LeasedAssetsHeldAsLessee2020-12-3107487836ns6:ComputerEquipmentns6:LeasedAssetsHeldAsLessee2021-01-012021-12-3107487836ns6:ComputerEquipmentns6:LeasedAssetsHeldAsLessee2021-12-3107487836ns6:ComputerEquipmentns6:LeasedAssetsHeldAsLessee2020-12-3107487836ns6:CostValuation2020-12-3107487836ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-3107487836ns6:WithinOneYearns6:CurrentFinancialInstruments2020-12-3107487836ns6:AfterOneYearns6:Non-currentFinancialInstruments2021-12-3107487836ns6:AfterOneYearns6:Non-currentFinancialInstruments2020-12-31
REGISTERED NUMBER: 07487836 (England and Wales)













WIMBLEDON NEUROCARE LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST DECEMBER 2021






WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2021










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


WIMBLEDON NEUROCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST DECEMBER 2021







DIRECTORS: Dr A Y M J Al-Memar
Dr O J F Foster





SECRETARY: Mr S Kumar





REGISTERED OFFICE: Unit 1 College Fields
16 Prince George Road
London
SW19 2PT





REGISTERED NUMBER: 07487836 (England and Wales)





ACCOUNTANTS: Sinclairs Bartrum Lerner
Chartered Accountants
Second Floor
34 Lime Street
London
EC3M 7AT

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

BALANCE SHEET
31ST DECEMBER 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 262,427 150,488
Investments 5 156,240 156,240
418,667 306,728

CURRENT ASSETS
Debtors 6 666,296 458,538
Cash at bank 344,727 309,612
1,011,023 768,150
CREDITORS
Amounts falling due within one year 7 234,546 75,293
NET CURRENT ASSETS 776,477 692,857
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,195,144

999,585

CREDITORS
Amounts falling due after more than one
year

8

(16,439

)

(22,136

)

PROVISIONS FOR LIABILITIES (40,059 ) (21,764 )
NET ASSETS 1,138,646 955,685

CAPITAL AND RESERVES
Called up share capital 514,048 514,048
Share premium 240,240 240,240
Retained earnings 384,358 201,397
SHAREHOLDERS' FUNDS 1,138,646 955,685

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

BALANCE SHEET - continued
31ST DECEMBER 2021


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13th May 2022 and were signed on its behalf by:




Dr O J F Foster - Director



Dr A Y M J Al-Memar - Director


WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2021


1. STATUTORY INFORMATION

Wimbledon Neurocare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

The financial statements are prepared in Pound Sterling which is the functional currency of the company and rounded to nearest pound.

Turnover
Turnover comprises revenue recognised by the company in respect of a range of services for the management of neurological conditions, hearing related conditions and balance disorders which includes assessment, diagnosis and treatment during the year, exclusive of Value Added Tax and trade discounts.

Services provided to patients are recognised as turnover according to the date when the treatments are provided.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery - 20% straight line on cost
Fixtures and fittings - 15% straight line on cost
Computer equipment - 20% straight line on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2021


2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Debtors and creditors
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Investments
Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through the profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2020 - 6 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1st January 2021 678,760 90,093 103,142 871,995
Additions 173,792 - 2,874 176,666
At 31st December 2021 852,552 90,093 106,016 1,048,661
DEPRECIATION
At 1st January 2021 582,430 70,880 68,197 721,507
Charge for year 44,865 4,250 15,612 64,727
At 31st December 2021 627,295 75,130 83,809 786,234
NET BOOK VALUE
At 31st December 2021 225,257 14,963 22,207 262,427
At 31st December 2020 96,330 19,213 34,945 150,488

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2021


4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts or finance leases are as follows:
Computer
equipment
£   
COST
At 1st January 2021
and 31st December 2021 31,599
DEPRECIATION
At 1st January 2021 4,213
Charge for year 5,267
At 31st December 2021 9,480
NET BOOK VALUE
At 31st December 2021 22,119
At 31st December 2020 27,386

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1st January 2021
and 31st December 2021 156,240
NET BOOK VALUE
At 31st December 2021 156,240
At 31st December 2020 156,240

6. DEBTORS
2021 2020
£    £   
Amounts falling due within one year:
Trade debtors 154,390 156,579
Other debtors 505,706 295,759
660,096 452,338

Amounts falling due after more than one year:
Other debtors 6,200 6,200

Aggregate amounts 666,296 458,538

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2021


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade creditors 178,071 19,026
Taxation and social security 22,328 27,835
Other creditors 34,147 28,432
234,546 75,293

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2021 2020
£    £   
Other creditors 16,439 22,136

9. OTHER FINANCIAL COMMITMENTS

The company acted as a guarantor to a lease agreement signed by a joint venture company (Sterling Healthcare Group Ltd) on 1st October 2020. That lease agreement covered the period from 1 October 2020 to 7 June 2047, with a rent of £189,688 per annum.